đź“‹ FDA Reference
philips uv-a solarium type hp 3141
Philips Int'L
Summary: The Philips UV-A Solarium Type HP 3141 is a medical device used for therapeutic UV-A light exposure. It is primarily utilized by dermatologists for treating skin conditions such as psoriasis and vitiligo.
FDA Clearance Information
Pathway
510K
Number
K851536 ↗
Decision Date
May 1, 1985
Product Code
FTC
Device Class
Class 2
Evidence
419 studies
The Philips UV-A Solarium Type HP 3141 was cleared through the FDA 510(k) pathway on May 1, 1985. Manufactured by Philips Int'L, it is classified as a Class 2 device under product code FTC.
What It Is
The Philips UV-A Solarium Type HP 3141 is a UV-A light therapy device designed to deliver controlled ultraviolet light exposure. It is used in dermatological settings to treat various skin conditions by modulating immune responses and reducing inflammation. The device typically consists of a series of UV-A lamps housed within a solarium unit, allowing for targeted or full-body exposure.
Clinical Applications
This device is commonly used in dermatology clinics for the management of chronic skin conditions such as psoriasis, eczema, and vitiligo. It is particularly beneficial for patients who have not responded well to topical treatments. The solarium is used in controlled clinical environments, ensuring precise dosimetry and minimizing the risk of adverse effects.
Indications for Use
The FDA indications suggest that this device is intended for patients with skin conditions that benefit from UV-A light therapy. Conditions like psoriasis, eczema, and vitiligo, which involve immune-mediated skin inflammation, are typical candidates for this treatment.
Practical Considerations
Clinicians should ensure proper calibration of the device to deliver accurate UV-A dosages. Protective eyewear is essential for both patients and operators to prevent UV-related eye damage. The device is compatible with standard dermatological practice settings and requires routine maintenance for optimal performance.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What is Philips UV-A Solarium Type HP 3141 used for?
It is used for therapeutic UV-A light exposure to treat skin conditions such as psoriasis and vitiligo.
What specialties typically use this device?
Dermatologists primarily use this device in clinical settings for treating chronic skin conditions.
What are the FDA-cleared indications?
The device is indicated for use in patients with skin conditions like psoriasis, eczema, and vitiligo that benefit from UV-A light therapy.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.